Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Pathogenesis and Management of Acute Kidney Injury in Patients with Nephrotic Syndrome Due to Primary Glomerulopathies.

Lionaki S, Liapis G, Boletis JN.

Medicina (Kaunas). 2019 Jul 11;55(7). pii: E365. doi: 10.3390/medicina55070365. Review.

2.

Arterial Stiffness in Patients With Renal Transplantation; Associations With Co-morbid Conditions, Evolution, and Prognostic Importance for Cardiovascular and Renal Outcomes.

Korogiannou M, Xagas E, Marinaki S, Sarafidis P, Boletis JN.

Front Cardiovasc Med. 2019 May 24;6:67. doi: 10.3389/fcvm.2019.00067. eCollection 2019. Review.

3.

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA; Conference Participants.

Kidney Int. 2019 Jun;95(6):1304-1317. doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.

PMID:
31053387
4.

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.

PMID:
30926722
5.

Impact of Primary Disease Nature in the Development of De Novo Donor-Specific Antibodies After Kidney Transplant and the Risk of Acute Rejection.

Lionaki S, Pappas A, Altanis N, Kapsia H, Liapis G, Vittoraki A, Iniotaki A, Zavos G, Boletis JN.

Exp Clin Transplant. 2019 Jun;17(3):304-312. doi: 10.6002/ect.2018.0054. Epub 2018 Oct 24.

6.

Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients.

Filiopoulos V, Sakellariou S, Papaxoinis K, Melexopoulou C, Marinaki S, Boletis JN, Delladetsima I.

Transplant Direct. 2018 Jul 20;4(8):e375. doi: 10.1097/TXD.0000000000000812. eCollection 2018 Aug.

7.

Coronary artery disease in renal transplant recipients: an angiographic study.

Paizis IA, Mantzouratou PD, Tzanis GS, Melexopoulou CA, Darema MN, Boletis JN, Barbetseas JD.

Hellenic J Cardiol. 2018 Jul 6. pii: S1109-9666(18)30101-5. doi: 10.1016/j.hjc.2018.07.002. [Epub ahead of print]

8.

Primary Hepatic Burkitt Lymphoma in a Kidney Transplant Recipient.

Lionaki S, Tsakonas E, Androulaki A, Liapis G, Panayiotidis P, Zavos G, Boletis JN.

Case Rep Nephrol. 2018 May 13;2018:7425785. doi: 10.1155/2018/7425785. eCollection 2018.

9.

IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology.

Stangou M, Papasotiriou M, Xydakis D, Oikonomaki T, Marinaki S, Zerbala S, Stylianou C, Kalliakmani P, Andrikos A, Papadaki A, Balafa O, Golfinopoulos S, Visvardis G, Moustakas G, Papachristou E, Kouloukourgiotou T, Kapsia E, Panagiotou A, Koulousios C, Kavlakoudis C, Georgopoulou M, Panagoutsos S, Vlahakos DV, Apostolou T, Stefanidis I, Siamopoulos K, Tzanakis I, Papadogiannakis A, Daphnis E, Iatrou C, Boletis JN, Papagianni A, Goumenos DS.

Clin Kidney J. 2018 Feb;11(1):38-45. doi: 10.1093/ckj/sfx076. Epub 2017 Jul 31.

10.

Hepatitis B in renal transplant patients.

Marinaki S, Kolovou K, Sakellariou S, Boletis JN, Delladetsima IK.

World J Hepatol. 2017 Sep 8;9(25):1054-1063. doi: 10.4254/wjh.v9.i25.1054. Review.

11.

The clinical course of IgA nephropathy after kidney transplantation and its management.

Lionaki S, Panagiotellis K, Melexopoulou C, Boletis JN.

Transplant Rev (Orlando). 2017 Apr;31(2):106-114. doi: 10.1016/j.trre.2017.01.005. Epub 2017 Feb 2. Review.

PMID:
28209246
12.

Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Lionaki S, Fragoulis GE, Venetsanopoulou A, Vlachoyiannopoulos P, Boletis JN, Tzioufas AG.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):155-164. Epub 2017 Jan 25.

PMID:
28134075
13.

The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries.

Lionaki S, Boletis JN.

Kidney Dis (Basel). 2016 Mar;1(4):224-34. doi: 10.1159/000442062. Epub 2015 Dec 5. Review.

14.

Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies.

Lionaki S, Gakiopoulou H, Boletis JN.

APMIS. 2016 Sep;124(9):725-35. doi: 10.1111/apm.12566. Epub 2016 Jun 30. Review.

PMID:
27356907
15.

Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis.

Lionaki S, Mavragani CP, Karras A, Liapis G, Somarakis G, Boletis JN, Drosos A, Tzioufas AG, Guillevin L, Moutsopoulos HM.

J Autoimmun. 2016 Aug;72:57-64. doi: 10.1016/j.jaut.2016.05.004. Epub 2016 May 15.

PMID:
27194577
16.

Renal transplantation with expanded criteria donors: Which is the optimal immunosuppression?

Filiopoulos V, Boletis JN.

World J Transplant. 2016 Mar 24;6(1):103-14. doi: 10.5500/wjt.v6.i1.103. Review.

17.

Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center.

Melexopoulou C, Marinaki S, Liapis G, Skalioti C, Gavalaki M, Zavos G, Boletis JN.

World J Transplant. 2015 Dec 24;5(4):329-37. doi: 10.5500/wjt.v5.i4.329.

18.

A Cytomegalovirus-related Pseudotumor in the Colon of A Renal Transplant Recipient Shrunk by Antiviral Therapy.

Lionaki S, Altanis N, Papaxoinis K, Delladetsima I, Daikos G, Boletis JN.

Transplantation. 2015 Jul;99(7):e46-7. doi: 10.1097/TP.0000000000000772. No abstract available.

PMID:
26147137
19.

Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression.

Siasos G, Tsigkou V, Oikonomou E, Zaromitidou M, Tsalamandris S, Mourouzis K, Vavuranakis M, Anastasiou M, Vlasis K, Limperi M, Gennimata V, Boletis JN, Papavassiliou AG, Tousoulis D.

Curr Med Chem. 2015;22(22):2619-35. Review.

PMID:
25876747
20.

Hepatitis C in hemodialysis patients.

Marinaki S, Boletis JN, Sakellariou S, Delladetsima IK.

World J Hepatol. 2015 Mar 27;7(3):548-58. doi: 10.4254/wjh.v7.i3.548. Review.

Supplemental Content

Loading ...
Support Center